Ssirai Kim
Senior Director at Eli Lilly and Company I Drug Development I Diversity I Patient Accessibility
- Role
- Senior Director, Portfolio Management and Clinical Delivery at Eli Lilly and Company
- Location
- Indianapolis, IN, US
- LinkedIn followers
- 500 followers
About Ssirai Kim
National award–winning healthcare professional and PhD-trained clinical researcher working across drug development and portfolio leadership. I support the advancement of Diabetes and Obesity assets from preclinical to key milestones, including candidate selection, IND/FHD, and board-level portfolio decisions.Focus areas: development strategy, obesity pipeline, portfolio governance, clinical design, patient accessibility, health equity research.
Experience
Senior Director, Portfolio Management and Clinical Delivery
Jan 2023 — Present · US
Portfolio Management – Early Phase COODriving early-phase strategy across Diabetes, Obesity, and Complications. Lead matrixed cross-functional teams to advance assets from preclinical to Phase 2 milestones. Accountable for portfolio entry, candidate selection, FPV-LPV planning, and regulatory interactions. Engage directly with executive governance bodies including the Obesity Board and Investment Committee to shape investment decisions and development strategy- Key areas: asset strategy, early development, decision governance, cross-functional leadership, R&D portfolio optimization, obesity pipeline.•Clinical Design, Development, and AnalyticsLed scientific and operational strategy for early- to late-phase trials, including Phase 2/3 protocol design in Neuroscience. Demonstrated impact of decentralized and community-based research models using quantitative evidence to improve patient access and reduce trial burden. Contributed to enterprise-wide initiatives to modernize clinical operations and accelerate innovation- Key areas: trial design, protocol development, patient-centricity, decentralized trials, operational innovation.•Selected for an accelerated leadership track (ARDLP) that provided enterprise-level exposure across Lilly’s R&D organization.
Education
Seoul National University
Bachelor of Science - BS, Nursing
2011
Duke University - The Fuqua School of Business
Master of Business Administration - MBA
2021 — 2023
Seoul National University
Doctor of Philosophy - PhD, Adult Nursing
2014 — 2021
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.